DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

Repligen Corp (NASDAQ: RGEN)

30.57 2.00 (7.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

RGEN $30.57 7.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $28.60
Previous Close $28.57
Daily Range $28.29 - $30.82
52-Week Range $12.04 - $34.15
Market Cap $1.0B
P/E Ratio 114.28
Dividend (Yield) $0.00 (0.0%)
Volume 326,720
Average Daily Volume 438,419
Current FY EPS $0.31




Drug Makers

Repligen Corp (RGEN) Description

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system. Website:

News & Commentary Rss Feed

Is This Tiny Biotech Still a Buy at All-Time Highs?

Repligen may not be on your watchlist, but it has been (very) good to investors in recent years. Will the ride continue?

Insider Trading Alert - RGEN, FGP And PSEM Traded By Insiders

A Tech Stocks Update for 2015

Repligen (RGEN) Enters Overbought Territory - Tale of the Tape

New Lifetime High Today: Repligen (RGEN)

The Hottest Opportunities in Tech Right Now

Repligen's (RGEN) CEO Walter Herlihy on Q4 2014 Results -- Earnings Call Transcript

Why Repligen Corporation Shares Manufactured a 13% Gain Today

Repligen Corporation shares rocketed higher. Here's what you need to know.

Friday's ETF Movers: PBE, PIN

Repligen (RGEN) Q4 2014 Results - Earnings Call Webcast

See More RGEN News...

RGEN's Top Competitors

RGEN $30.57 (7.00%)
Current stock: RGEN
GILD $101.00 (-0.07%)
Current stock: GILD
CELG $118.68 (0.87%)
Current stock: CELG
AMGN $162.59 (1.27%)
Current stock: AMGN